Welcome to Potsdam!
On behalf of GUM and EEMGS we invite you to the 46th EEMGS/30th GUM meeting, to be held in Potsdam, Germany from 18th to the 21st of March 2018.
The Scientific Program Committee is preparing an exciting program that will highlight a wide diversity of aspects in the field of genetic toxicology. We are proud to be able to present an array of excellent speakers and key note lecturers covering a variety of current aspects in relation to DNA damage and mutations caused by environmental agents, cell-type specificity of genotoxicity and DNA repair, alternatives to animals testing including emerging models and techniques, new approaches in human biomonitoring, hot topics in carcinogenicity, next generation risk assessment in genotoxicity and genome safety in gene therapy. In addition, participants will have the opportunity to attend the HESI GTTC workshop: “Applied Genetic Toxicity for Regulatory Decision Making: The Road Ahead” which will be taking place after the EEMGS meeting at the same venue.
Selected abstracts will be chosen for oral presentations. Poster sessions will be held and we kindly invite all participants to submit their work for any kind of presentation. Participation of young scientists is particularly encouraged, and we offer reduced conference fees and invite to apply for travel bursaries.
We are looking forward to your participation which will be a key part for an enjoyable and successful conference.
Prof. Dr. Helga Stopper: EEMGS President
Dr. Albrecht Pohl: GUM President
Prof. Dr. Tanja Schwerdtle and Dr. Julia Bornhorst: Local Organizers
Prof. Dr. Helga Stopper
Dr. Albrecht Poth
Prof. Dr. Tanja Schwerdtle
Dr. Julia Bornhorst
- Cell-Type Specificity Of Genotoxicity And DNA Repair
- DNA Damage Response And DNA Repair
- Alternatives To Animal Testing: Emerging Models And Techniques
- Mutagenicity And Aging
- Discovering Causes Of Disease: New Approaches In Human Biomonitoring
- Environmental Health and Early Life Exposure
- Hot Topics In Carcinogenicity
- Understanding Mechanisms Underlying Mutational Signatures In Human Cancer Using Whole Genome Sequencing
- Next Generation Risk Assessment Of Genetic Toxicity
- Testing Of Impurities For Mutagenic Potential In Drugs, Substances And Products
- Genome Safety In Gene Therapy
V.M. Arlt, H.-J. Martus, J. Bornhorst, R. Frötschl, B. Epe, E. Knudsen,
G. Johnson, A. Poth, S. Langie, H. Stopper, T. Schwerdtle